Thyrocare Technologies posts Q4 FY24 consolidated PAT at Rs. 17.78 Cr

The company has posted net profit of Rs.70.76 crores for the Financial Year ended March 31, 2024

Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan

Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA

ANVISA issues CGMP to Concord Biotech’s Unit I

Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr

Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023

Nethradhama’s conference on ophthalmology sees launch of advanced eye care technologies

The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)

Cipla Technologies, Pulmatrix agree for development and commercialization of Pulmazole

Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America

Inspira Technologies closes on $3.88 million RDO

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering

AstraZeneca to acquire China's Gracell Biotechnologies for US $1.2 billion

Furthering cell therapy ambition across oncology and autoimmune diseases

Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr

Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023

Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery

Three block copolymers added to RESOMER portfolio of bioabsorbable polymers